BioCentury | May 9, 2020
Product Development

China emerging as a leader in COVID-19 vaccines

...for both programs in the form of a partnership with the Institute of Biotechnology of the Academy of Military Medical Sciences...
BioCentury | May 2, 2020
Product Development

End of the beginning for COVID-19 vaccines

...billion dollars from BARDA. CanSino Biologics Inc. (HKEX:6185) has backing from the Chinese government via the Academy of Military Medical Sciences’...
BioCentury | Apr 10, 2020
Product Development

COVID-19 roundup: New immune targets to address pandemic; plus updates from CanSino, Arcturus, Fujifilm and more

...Inc. (HKEX:6185) to plan a Chinese Phase II trial, starting soon. CanSino co-developed Ad5-nCoV with the Academy of Military Medical Sciences...
BioCentury | Mar 19, 2020
Product Development

Roivant pivots towards ARDS in COVID-19; plus Italian studies of repurposed anti-inflammatories, vaccine updates and more

...to begin Phase I testing in China for Ad5-nCoV, a COVID-19 vaccine it co-developed with the Academy of Military Medical Sciences...
BioCentury | Mar 18, 2020
Product Development

COVID-19 roundup: BioNTech, Pfizer co-developing vaccine, plus updates from Regeneron, Novartis, CureVac, Fujifilm and CanSino

...would provide the drug to COVID-19 patients free of charge. CanSino Biologics Inc. (HKEX:6185) and the Academy of Military Medical Sciences...
BioCentury | Sep 13, 2019
Distillery Therapeutics

Peptide-macrocycle conjugates for breast cancer

...The Academy of Military Medical Sciences, Beijing, China email: nankaimqb@sina.com CONTACT: Chunju Li, Shanghai University, Shanghai, China email: cjli@shu.edu.cn Claire Quang Shanghai University The Academy of Military Medical Sciences Integrin...
BioCentury | Oct 25, 2018
Distillery Therapeutics

Infectious disease

...The Academy of Military Medical Sciences, Beijing, China email: zhongwu@bmi.ac.cn CONTACT: Keliang Liu, same affiliation as above email: keliangliu55@126.com Claire Quang Fudan University The Academy of Military Medical Sciences Ebola...
BioCentury | Mar 7, 2018
Distillery Therapeutics

Infectious disease

...Jiang, Fudan University, Shanghai, China, email: shibojiang@fudan.edu.cn CONTACT: Keliang Liu, Academy of Military Medical Sciences, Beijing, China email: keliangliu55@126.com Mark Zipkin Academy of Military Medical Sciences Fudan...
BioCentury | Dec 8, 2014
Company News

Academy of Military Medical Sciences, Sihuan deal

...approval. The small molecule RNA polymerase selective inhibitor is in development to treat Ebola infection. The Academy of Military Medical Sciences...
BioCentury | Oct 24, 2011
Company News

Agenix, Chinese Academy of Medical Sciences, Chinese Institute of Pharmacology and Toxicology of the Academy of Military Medical Sciences deal

...Chinese Academy of Medical Sciences , Beijing, China Chinese Institute of Pharmacology and Toxicology of the Academy of Military Medical Sciences...
Items per page:
1 - 10 of 10
BioCentury | May 9, 2020
Product Development

China emerging as a leader in COVID-19 vaccines

...for both programs in the form of a partnership with the Institute of Biotechnology of the Academy of Military Medical Sciences...
BioCentury | May 2, 2020
Product Development

End of the beginning for COVID-19 vaccines

...billion dollars from BARDA. CanSino Biologics Inc. (HKEX:6185) has backing from the Chinese government via the Academy of Military Medical Sciences’...
BioCentury | Apr 10, 2020
Product Development

COVID-19 roundup: New immune targets to address pandemic; plus updates from CanSino, Arcturus, Fujifilm and more

...Inc. (HKEX:6185) to plan a Chinese Phase II trial, starting soon. CanSino co-developed Ad5-nCoV with the Academy of Military Medical Sciences...
BioCentury | Mar 19, 2020
Product Development

Roivant pivots towards ARDS in COVID-19; plus Italian studies of repurposed anti-inflammatories, vaccine updates and more

...to begin Phase I testing in China for Ad5-nCoV, a COVID-19 vaccine it co-developed with the Academy of Military Medical Sciences...
BioCentury | Mar 18, 2020
Product Development

COVID-19 roundup: BioNTech, Pfizer co-developing vaccine, plus updates from Regeneron, Novartis, CureVac, Fujifilm and CanSino

...would provide the drug to COVID-19 patients free of charge. CanSino Biologics Inc. (HKEX:6185) and the Academy of Military Medical Sciences...
BioCentury | Sep 13, 2019
Distillery Therapeutics

Peptide-macrocycle conjugates for breast cancer

...The Academy of Military Medical Sciences, Beijing, China email: nankaimqb@sina.com CONTACT: Chunju Li, Shanghai University, Shanghai, China email: cjli@shu.edu.cn Claire Quang Shanghai University The Academy of Military Medical Sciences Integrin...
BioCentury | Oct 25, 2018
Distillery Therapeutics

Infectious disease

...The Academy of Military Medical Sciences, Beijing, China email: zhongwu@bmi.ac.cn CONTACT: Keliang Liu, same affiliation as above email: keliangliu55@126.com Claire Quang Fudan University The Academy of Military Medical Sciences Ebola...
BioCentury | Mar 7, 2018
Distillery Therapeutics

Infectious disease

...Jiang, Fudan University, Shanghai, China, email: shibojiang@fudan.edu.cn CONTACT: Keliang Liu, Academy of Military Medical Sciences, Beijing, China email: keliangliu55@126.com Mark Zipkin Academy of Military Medical Sciences Fudan...
BioCentury | Dec 8, 2014
Company News

Academy of Military Medical Sciences, Sihuan deal

...approval. The small molecule RNA polymerase selective inhibitor is in development to treat Ebola infection. The Academy of Military Medical Sciences...
BioCentury | Oct 24, 2011
Company News

Agenix, Chinese Academy of Medical Sciences, Chinese Institute of Pharmacology and Toxicology of the Academy of Military Medical Sciences deal

...Chinese Academy of Medical Sciences , Beijing, China Chinese Institute of Pharmacology and Toxicology of the Academy of Military Medical Sciences...
Items per page:
1 - 10 of 10